Skip to main content

imipenem-cilastatin

Generic: cilastatin·Brand: Primaxin

imipenem-cilastatin: 1 clinical trial tracked.

imipenem-cilastatin evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about imipenem-cilastatin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Clinical Trial Registry Records (1)

A Phase 3, Randomized, Double-blind, Double-dummy, Multicenter, Multinational Study to Assess the Efficacy and Safety of Orally Administered Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenously Administered Imipenem-cilastatin in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

NCT06059846Registry updated 2026-03-10·Phase 3·SPRO
Completed

Primary endpoint: Number of Participants With Overall Response at the Test-of-Cure (TOC) Visit in the Microbiological Intent-to-Treat (Micro-ITT) Population

InterventionalRandomizedtriple1,690 enrolledStarted 2023-12Completion 2025-0250 sites · Argentina, Bosnia and Herzegovina, Brazil, Bulgaria…Spero Therapeutics